Search - tctmd.com

Displaying 521 - 540 of 849

Sort: Relevancy | Date

News Industry News

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

June 24, 2019

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

News Conference News TVT 2019

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Michael O'Riordan

June 17, 2019

News Conference News TVT 2019

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Shelley Wood

June 17, 2019

News Conference News TVT 2019

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Michael O'Riordan

June 14, 2019

Presentation TVT 2019

Mitral Valve-In… -Valve and -Ring I: Insights From the Registries/Trials

Presenter: Mayra Guerrero

June 14, 2019

Presentation TVT 2019

Valve Performance and Durability After Transcatheter Versus Surgical Aortic Valve Replacement — A Meta-Analysis of Randomized Controlled Trials

Presenter: Ankur Sethi

June 14, 2019

Presentation TVT 2019

Which Patients Are Best Candidates for Clinical Trials With… Transcatheter Mitral Valve Replacement (Anatomic and Clinical Factors)

Presenter: Thomas Modine

June 14, 2019

Presentation TVT 2019

Which Patients Are Best Candidates for Clinical Trials With… Transcatheter Leaflet/Chordal Suspension (Anatomic and Clinical Factors)

Presenter: Steven Bolling

June 14, 2019

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

Presentation TVT 2019

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

Presenter: Martin Leon

June 13, 2019

Presentation TVT 2019

A Synthesis of COAPT, MitraFR, and Other FMR Trials: Clinical Implications

Presenter: Gregg Stone

June 13, 2019

News Daily News

Potential Warning Signs Seen for NOAC Use After TAVR

Todd Neale

June 12, 2019

News Daily News

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Yael L. Maxwell

June 11, 2019

News Daily News

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Michael O'Riordan

June 11, 2019

News Features ESC Heart Failure 2019

At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback

Shelley Wood

May 30, 2019

News Conference News SCAI 2019

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Yael L. Maxwell

May 30, 2019

News Conference News ESC Heart Failure 2019

MitraClip Benefits FMR Patients Regardless of Baseline BNP: COAPT

Shelley Wood

May 27, 2019

Advertisement

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Mitral Valve-In… -Valve and -Ring I: Insights From the Registries/Trials

Valve Performance and Durability After Transcatheter Versus Surgical Aortic Valve Replacement — A Meta-Analysis of Randomized Controlled Trials

Which Patients Are Best Candidates for Clinical Trials With… Transcatheter Mitral Valve Replacement (Anatomic and Clinical Factors)

Which Patients Are Best Candidates for Clinical Trials With… Transcatheter Leaflet/Chordal Suspension (Anatomic and Clinical Factors)

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

A Synthesis of COAPT, MitraFR, and Other FMR Trials: Clinical Implications

Potential Warning Signs Seen for NOAC Use After TAVR

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

MitraClip Benefits FMR Patients Regardless of Baseline BNP: COAPT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content